Total Payments
$74,787
2024 Payments
$19,559
Companies
47
Transactions
542
Medicare Patients
4,082
Medicare Billing
$484,165
Payment Breakdown by Category
Other$58,770 (78.6%)
Food & Beverage$11,231 (15.0%)
Travel$2,894 (3.9%)
Consulting$1,860 (2.5%)
Education$31.80 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $58,770 | 42 | 78.6% |
| Food and Beverage | $11,231 | 477 | 15.0% |
| Travel and Lodging | $2,894 | 18 | 3.9% |
| Consulting Fee | $1,860 | 1 | 2.5% |
| Education | $31.80 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $22,104 | 39 | $0 (2019) |
| ABBVIE INC. | $17,757 | 171 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $15,494 | 36 | $0 (2024) |
| Synergy Pharmaceuticals Inc | $11,386 | 30 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $1,860 | 1 | $0 (2022) |
| Janssen Biotech, Inc. | $450.56 | 24 | $0 (2024) |
| GENZYME CORPORATION | $436.79 | 17 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $404.65 | 23 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $344.25 | 3 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $317.40 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19,559 | 92 | Phathom Pharmaceuticals, Inc. ($15,477) |
| 2023 | $6,897 | 71 | ABBVIE INC. ($5,690) |
| 2022 | $7,370 | 90 | ABBVIE INC. ($4,651) |
| 2021 | $3,530 | 32 | AbbVie Inc. ($3,361) |
| 2020 | $533.76 | 34 | AbbVie Inc. ($205.93) |
| 2019 | $2,970 | 65 | Allergan Inc. ($1,878) |
| 2018 | $16,097 | 83 | Synergy Pharmaceuticals Inc ($11,252) |
| 2017 | $17,830 | 75 | Allergan Inc. ($16,593) |
All Payment Transactions
542 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 12/02/2024 | ABBVIE INC. | LINZESS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,425.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | LINZESS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,425.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $7.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | Stryker Corporation | PEDI-POM (Device) | Food and Beverage | In-kind items and services | $28.34 | General |
| Category: INSTRUMENTS | ||||||
| 11/15/2024 | Stryker Corporation | N/A (Device) | Food and Beverage | In-kind items and services | $64.86 | General |
| Category: NEURO SPINE ENT | ||||||
| 11/15/2024 | Stryker Corporation | N/A (Device) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: NEURO SPINE ENT | ||||||
| 11/14/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/25/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/24/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: LIVER DISEASE | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: INFLIXIMAB | ||||||
| 09/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: Immunology | ||||||
| 09/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $10.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: Immunology | ||||||
| 09/04/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $115.00 | General |
| Category: Rare Disease | ||||||
| 09/04/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 08/28/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $860.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.80 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $7.80 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,305 | 1,612 | $791,218 | $155,249 |
| 2022 | 19 | 1,094 | 1,424 | $708,067 | $131,087 |
| 2021 | 19 | 873 | 1,055 | $488,520 | $103,049 |
| 2020 | 16 | 810 | 1,050 | $477,486 | $94,780 |
Total Patients
4,082
Total Services
5,141
Medicare Billing
$484,165
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2023 | 54 | 54 | $126,900 | $31,049 | 24.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 112 | 114 | $123,261 | $22,137 | 18.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 181 | 256 | $60,160 | $16,862 | 28.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 123 | 123 | $63,960 | $13,834 | 21.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 104 | 116 | $31,552 | $10,796 | 34.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 108 | 111 | $97,014 | $9,522 | 9.8% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 153 | 309 | $58,710 | $8,322 | 14.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 52 | 53 | $54,233 | $5,185 | 9.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 28 | 28 | $22,220 | $3,932 | 17.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 22 | 22 | $17,329 | $3,790 | 21.9% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 38 | 54 | $10,260 | $3,646 | 35.5% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 40 | 64 | $12,160 | $3,538 | 29.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 35 | 35 | $12,180 | $3,522 | 28.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 41 | 56 | $10,248 | $3,424 | 33.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 39 | 39 | $25,179 | $3,339 | 13.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 36 | 36 | $9,864 | $2,799 | 28.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 13 | 13 | $10,504 | $2,306 | 22.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 50 | 52 | $5,772 | $2,142 | 37.1% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2023 | 12 | 12 | $13,476 | $1,728 | 12.8% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 15 | 15 | $13,410 | $1,657 | 12.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 23 | 24 | $2,400 | $924.00 | 38.5% |
| 43450 | Dilation of esophagus | Facility | 2023 | 26 | 26 | $10,426 | $793.28 | 7.6% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2022 | 42 | 44 | $103,400 | $27,021 | 26.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 107 | 107 | $115,659 | $20,973 | 18.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 113 | 113 | $58,760 | $12,206 | 20.8% |
About Dr. Adam Levy, M.D
Dr. Adam Levy, M.D is a Gastroenterology healthcare provider based in Macon, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1851504989.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adam Levy, M.D has received a total of $74,787 in payments from pharmaceutical and medical device companies, with $19,559 received in 2024. These payments were reported across 542 transactions from 47 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($58,770).
As a Medicare-enrolled provider, Levy has provided services to 4,082 Medicare beneficiaries, totaling 5,141 services with total Medicare billing of $484,165. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Macon, GA
- Active Since 05/07/2007
- Last Updated 09/04/2013
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1851504989
Products in Payments
- LINZESS (Drug) $34,693
- VOQUEZNA (Drug) $15,494
- Trulance (Drug) $11,386
- VIBERZI (Drug) $2,748
- FASENRA (Biological) $1,860
- DUPIXENT (Biological) $896.34
- RINVOQ (Biological) $543.77
- STELARA (Biological) $505.12
- ZEPOSIA (Drug) $475.13
- Mavyret (Drug) $342.81
- ENTYVIO (Biological) $332.26
- XIFAXAN (Drug) $287.92
- HUMIRA (Biological) $286.31
- MAVYRET (Drug) $283.13
- XELJANZ (Drug) $277.06
- OCALIVA (Drug) $261.54
- Humira (Biological) $239.15
- REMICADE (Biological) $222.92
- Sucraid (Drug) $211.78
- CREON (Drug) $203.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Macon
Dr. Daniel Penn, M.d, M.D
Gastroenterology — Payments: $196,237
Gastroenterology $196,237
Dr. Raymond Bedgood, D.o, D.O
Gastroenterology — Payments: $21,324
Gastroenterology $21,324
Joel Judah, Md, MD
Gastroenterology — Payments: $13,591
Gastroenterology $13,591
Carley Ebanks, M.d, M.D
Gastroenterology — Payments: $8,960
Gastroenterology $8,960
Dr. William Fackler, Md, MD
Gastroenterology — Payments: $7,328
Gastroenterology $7,328
Shahriar Sedghi, M.d, M.D
Gastroenterology — Payments: $7,263
Gastroenterology $7,263